OPDIVO 40 MG / 4 ML ( NIVOLUMAB 10 MG / ML ) FOR INTRAVENOUS INFUSION USE 4 ML VIAL
rash
decreased appetite
constipation
itching
The most common side effects of OPDIVO when used in combination with chemotherapy include:
nausea
feeling tired
pain in muscles, bones and joints
constipation
decreased appetite
rash
vomiting
numbness, pain, tingling, or burning in your hands and feet
The most common side effects of OPDIVO when used in combination with cabozantinib include:
diarrhea
feeling tired or weak
liver problems
rash, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet
mouth sores
rash
high blood pressure
low thyroid hormone levels
pain in muscles, bones, and joints
decreased appetite
nausea
change in the sense of taste
stomach-area (abdominal) pain
cough
upper respiratory tract infection
The most common side effects of OPDIVO when used in combination with fluoropyrimidine- and platinum-containing chemotherapy include:
nausea
numbness, pain, tingling, or burning in your hands or feet
decreased appetite
feeling tired
constipation
mouth sores
diarrhea
vomiting
stomach-area (abdominal) pain
pain in muscles, bones, and joints
These are not all the possible side effects. Talk to your healthcare team or pharmacist for more information. You are encouraged to report side effects of prescription drugs to the FDA. Call 1-800-FDA-1088.
What should I discuss with my healthcare team before receiving OPDIVO or YERVOY?
Tell your healthcare provider about all your medical conditions, including if you:
have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
have received an organ transplant, including corneal transplant
have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
have received radiation treatment to your chest area in the past and have received other medicines that are like OPDIVO
have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
are pregnant or plan to become pregnant. OPDIVO and YERVOY can harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if OPDIVO or YERVOY passes into your breast milk. Do not breastfeed during treatment and for 5 months after your last dose of OPDIVO or YERVOY.
Females who are able to become pregnant:
Your healthcare provider should do a pregnancy test before you start receiving OPDIVO or YERVOY.
You should use an effective method of birth control during your treatment and for 5 months after the last dose of OPDIVO or YERVOY. Talk to your healthcare provider about birth control methods that you can use during this time.
Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with OPDIVO or YERVOY. You or your healthcare provider should contact Uk-online-pharmacy at +44 7397 146047 as soon as you become aware of a pregnancy.
Tell your healthcare provider about all the medicines you take, including:
prescription medicines
over-the-counter medicines
vitamins
herbal supplements